Fresh2 Group Limited

FRES Stock Healthcare Biotechnology
$0.85
+0.00 (+0.00%)
Price as of Oct 14, 2026 market close

Performance

1 Month
+0.0%
3 Months
+0.0%
YTD
+0.0%
1 Year
-56.4%
3 Year annualized
-49.9%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Volatility 1-year annualized
81.9%
Largest decline max drawdown, since May 2023
-98.4%
Risk-adjusted return Sharpe ratio, 1-year
-0.61

Own FRES?

See how FRES contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.